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Characterisation of the hydrogels
Addition of HACS and CNTs to chitosan gels
reduced the gelation time from 60 min to 7 and 9
min (for SWNTs and MWNTs respectively); the
injection force was also reduced (Table 1) while the
compressibility after gelation was significantly
increased (Fig 5).
In vitro calcification studies
EDS coupled SEM analysis revealed significantly higher deposition of Ca and P salts on the composites
surface and microCT analysis showed a more homogenous internal distribution of precipitated salts and
more stable porous structure for hydrogels containing CNTs in comparison to chitosan only gels (Fig 1-4).
Fig. 1 Overlay images of SEM pictures with EDS data:
calcium (green), phosphorus (red) and co-localisation of
Ca/P (yellow) for gels incubated in SBF for 0, 7 and 14 days.
Fig. 2 Quantitative analysis of surface calcium
deposition presenting % of surface covered by co-
localised Ca and P (from EDS coupled SEM). Data
are reported as mean ± SD (n=3). One-way ANOVA
and Tukey post-hoc test performed.
Fig. 3 Average % salt deposition on different types of
hydrogel samples (from microCT). Data are reported
as mean ± SD (n=5).
All the tested hydrogels showed the potential to
provide controlled release within the 2 weeks of the
experiment (Fig. 6).
Release of model drugs
Fig. 6 Release profile of A) BSA and B) OVA from ( ) chitosan; ( ) CS-
HACS-SWNTs; ( ) CS-HACS-MWNTs gels. Data are reported as mean ± SD
(n = 3).
Conclusions
• CNTs were successfully non-covalently stabilised and included into hydrophilic chitosan hydrogels.
• The non-covalent stabilisation of nanotubes facilitated the injectability of the formulation while improving the
mechanical performance once gelled. CNTs also proved to be key in guaranteeing a homogeneous deposition
of salts suggesting that they can be used for guided mineralisation of scaffolds for bone regeneration.
• Finally the formulated gels presented a great potential as platforms for prolonged drug delivery. References
[1] Lu XY, Qiu T, Wang XF, Zhang M, Gao XL, Li RX et al. Appl. Surface Sci. 2012; 262: 227-30.
[2] Porter JR, Ruckh TT, Popat KC. Biotechnol. Progr. 2009; 25(6):1539-60.
[3] Klouda L, Mikos AG. Eu. J. Pharm. Biopharm. 2008; 68(1): 34-45.
[4] Piovesan S, Cox PA, Smith JR, Fatouros DG, Roldo M. PCCP 2010; 12: 15636-43.
[5] Tanese CE, Popa MI, Verestiuc L. Mater. Letters. 2011:65: 1681-3.
Fig. 4 Representative micro CT slices of different gel samples 
incubated in SBF for 0, 7 and 14 days.
Introduction 
Current treatments for bone fractures involve auto/
allo-grafts, or the use of metallic/ceramic implants
that present many shortcomings such as surgical
invasiveness, rejection and bacterial infection [1].
Bone tissue engineering (BTE) aims to develop
temporary biocompatible scaffolds to support tissue
ingrowth [2]. Among the possible scaffolds for BTE,
chitosan (CS) based hydrogels represent
advantageous systems due to their
biocompatibility, biodegradability and antibacterial
properties. Furthermore, they can be formulated as
thermosensitive hydrogels that can be injected and
avoid invasive procedures [3]. However, these
chitosan systems show poor mechanic
performances that could not support load-bearing
applications. In order to produce more
mechanically-competent biomaterials, the
combined addition of hydroxyapatite (HA) and
carbon nanotubes (CNTs) has been evaluated.
Aims
• To design a flexible hydrogel formulation that
allows the inclusion of single walled (SWNTs) and
multiwalled (MWNTs) CNTs by a non-covalent
stabilisation method using the biocompatible
polymer N-octyl-O-sulphate chitosan (NOSC) [4].
• To study the mechanical and physiochemical
properties, calcium deposition patterns and
ability to provide a platform for the controlled
release of protein drugs from the gels.
Formulation Composition Plateau
force (N) 
(A) Chitosan 8.56 ± 0.29
(B) Chitosan – HACS 8.56 ± 0.34
(C) Chitosan – HACS-(NOSC-SWNTs) 6.40 ± 0.24***
(D) Chitosan – HACS-(NOSC-MWNTs) 6.92 ± 0.15***
Table 1. Syringeability of
composite formulations.
Determined by compression
testing using a TA texture analysis
apparatus. Plateau force is
expressed as mean ± SD (n=3).
Fig. 5 Compressibility of the different
formulations before (grey) and after (black)
sol/gel transition. Results are reported as
mean ± SD (n=3). One-way ANOVA
(α=0.05) p < 0.0001 for both gels containing
CNTs; Tukey’s multicomparison test, ***
p<0.001 compred to control at time zero,
### p<0.001 compared to a specific
sample.
Methods 
Formulation of hydrogels: chitosan solutions were mixed with
hydroxyapatite/chitosan composites (HACS) and SWNTs or
MWNTs suspended in N-octyl-O-sulphate chitosan (NOSC).
Glycerol phosphate (GP) was added as crosslinker agent
(1.12 g/ml). Gelation was obtained by incubation at 37° C.
Texture analysis: syringeabilty of the suspensions before
gelation and texture profiles were determined by a Texture
analyser.
In vitro calcification studies: freeze dried gels were immersed
into simulated body fluid (SBF) for 7 and 14 days. Then, they
have been examined by EDS coupled SEM and microCT.
Release of model drugs: bovine serum albumin (BSA, 1
mg/ml) was included into the suspensions (5 ml). Then 5 ml
PBS were added. Ovalbumin (OVA, 1 mg/ml) was firstly
included into the suspensions. Then, 1 g of the suspensions
were transferred into a Flot-A-Lyzer dilalysis device and 15 ml
of PBS were added. The BSA and OVA samples were
incubated at 37° C for 14 days. Acknowledgements: This research was co-funded by the Institute of Biomedical and Biomolecular Science Quality Research Fund and the Research 
Development Fund of the University of Portsmouth, UK.
FORMULATION METHOD
(A) 200 mg Chitosan in 7 ml lactic acid (0.1 M)
(B) 86 mg of HACS composites [5] were dispersed in
(A)
(C) 2.5 mg SWNTs were added to a NOSC solution
(1.25 mg/ml), sonicated for 2 hours, overnight rest
and sonicated for 1 h. Then 2 ml of NOSC
stabilised SWNTs were added to (B)
(D) 2.5 mg mWNTs were added to a NOSC solution
(1.25 mg/ml), sonicating for 2 hours, overnight
rest and sonication for 1 h. Then 2 ml of NOSC
stabilised SWNTs were added to (B)
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